Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

David W. Chang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7106-7945; OpenAlex author ID A5103062167. Sources: funder_awards.

Their work

Papers
1
Trials
0
Grants
1
Labs led
0
Collaborators
3
Papers, trials and grants by year

2006: 1 grant · 2007: none · 2008: none · 2009: none · 2010: none · 2011: none · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper

Papers 1

  1. Determinants and prognostic value of quality of life in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.ejca.2017.12.023↗

Grants 1

  1. Treating Pancreatic Cancer with the Well-Characterized Anti-Allergy Drug Cromolyn Through a Novel Mechanism of Action AWARD pancan:2006-david-z-chang-md-phd-treating-pancreatic-cancer-with-the-well

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xifeng Wu · 1 shared paper, 2018 · strength 0.07
  2. Yang Deng · 1 shared paper, 2018 · strength 0.07
  3. Alison P. Klein · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.